EA
NEOS

Emerald Advisers’s Neos Therapeutics, Inc NEOS Stock Holding History

Emerald Advisers’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-336,550
Closed -$3.63M – 334
2016
Q1 		$3.63M Sell
336,550
-42,324
-11% -$446K 0.18% 153
2015
Q4 		$5.42M Buy
378,874
+57,561
+18% +$868K 0.26% 120
2015
Q3 		$6.75M Buy
+321,313
New +$7.08M 0.35% 98

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Emerald Advisers's NEOS Position: Q2 2016 in Review

Emerald Advisers sold out of Neos Therapeutics, Inc (NEOS) in Q2 2016, closing a stake of 336,550 shares — an estimated $3.63M sold.

Emerald Advisers first reported a position in NEOS in Q3 2015 and held it in 3 quarters. The position peaked at $6.75M in Q3 2015. 46 funds tracked by Wall St. Rank hold NEOS as of Q2 2016.

  • Emerald Advisers reported no remaining Neos Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
  • Emerald Advisers sold 336,550 Neos Therapeutics, Inc shares in Q2 2016, an estimated $3.63M.
  • Emerald Advisers first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 3 quarters.
  • Emerald Advisers's Neos Therapeutics, Inc position peaked at $6.75M in Q3 2015.
  • 46 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2016.

Based on Emerald Advisers's 13F filing for Q2 2016, filed 28 Jul 2016.